These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32158176)

  • 1. Prevalence of Congenital Malaria in Kisangani, A Stable Malaria Transmission Area in Democratic Republic of the Congo.
    Otuli Noël L; Nguma Jean-Didier B; Alongo Mike-Antoine M; Bosunga Gedeon K; Mukonkole Jean-Paulin M; Likwela Joris L; Okenge Jean-Pascal M
    Infect Dis Obstet Gynecol; 2020; 2020():2176140. PubMed ID: 32158176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
    Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW
    Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Malaria Interventions During Pregnancy on Low Birth Weight in Malawi.
    Nkoka O; Chuang TW; Chen YH
    Am J Prev Med; 2020 Dec; 59(6):904-913. PubMed ID: 33220759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of intermittent preventive therapy in the eradication of peripheral and placental parasitemia in a malaria-endemic environment, as seen in a tertiary hospital in Abuja, Nigeria.
    Umemmuo MU; Agboghoroma CO; Iregbu KC
    Int J Gynaecol Obstet; 2020 Mar; 148(3):338-343. PubMed ID: 31833060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
    Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of malarial prophylaxis with mefloquine during pregnancy in Kisangani, Democratic Republic of Congo: A randomized clinical trial.
    Labama Otuli N; Marini Djang'eing'a R; Losimba Likwela J; Bosenge Nguma JD; Maindo Alongo MA; Ahuka Ona Longombe A; Mbutu Mango B; M N Bono D; L Mokili J; Manga Okenge JP
    Br J Clin Pharmacol; 2021 Aug; 87(8):3115-3126. PubMed ID: 33398890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
    Taylor SM; van Eijk AM; Hand CC; Mwandagalirwa K; Messina JP; Tshefu AK; Atua B; Emch M; Muwonga J; Meshnick SR; Ter Kuile FO
    J Infect Dis; 2011 Dec; 204(11):1762-71. PubMed ID: 21990422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
    Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, Nigeria.
    Tongo OO; Orimadegun AE; Akinyinka OO
    BMC Pregnancy Childbirth; 2011 Aug; 11():60. PubMed ID: 21851610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of pregnancy-associated malaria by microscopy, rapid diagnostic test and PCR in Bandundu, the Democratic Republic of Congo.
    Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
    Trans R Soc Trop Med Hyg; 2018 Jan; 112(1):8-13. PubMed ID: 29554347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
    Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
    ter Kuile FO; van Eijk AM; Filler SJ
    JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
    Tarimo SD
    East Afr J Public Health; 2007 Oct; 4(2):80-3. PubMed ID: 18085136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.